ストックスクリーナーアプリを入手
20.51
2.77%
-0.58
前日終値:
$21.09
開ける：
$20.85
24時間の取引高:
1.00M
Relative Volume:
0.61
時価総額：
$1.31B
収益：
-
当期純損益:
$-107.85M
株価収益率:
-9.2805
EPS:
-2.21
ネットキャッシュフロー:
$-106.82M
1週間 パフォーマンス:
-6.28%
1か月 パフォーマンス:
-12.97%
6か月 パフォーマンス:
-45.00%
1年 パフォーマンス:
-43.96%
1日の値動き範囲:
$20.30
$21.14
1週間の範囲:
$20.30
$21.93
52週間の値動き範囲:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
名前
Vera Therapeutics Inc
セクター
電話
650-770-0077
住所
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
VERA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
20.48 | 1.32B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
548.85 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
390.05 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
675.94 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
300.32 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-05 | 再開されました | H.C. Wainwright | Buy |
| 2025-02-04 | 開始されました | Wolfe Research | Outperform |
| 2025-01-28 | 開始されました | Goldman | Buy |
| 2024-11-21 | 開始されました | Wells Fargo | Overweight |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-01-25 | 開始されました | Oppenheimer | Outperform |
| 2024-01-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-12-18 | 開始されました | Raymond James | Outperform |
| 2023-11-10 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-16 | 開始されました | Guggenheim | Buy |
| 2023-01-04 | ダウングレード | Jefferies | Buy → Hold |
| 2023-01-04 | ダウングレード | Wedbush | Outperform → Neutral |
| 2022-07-12 | 開始されました | JP Morgan | Overweight |
| 2022-05-02 | 開始されました | H.C. Wainwright | Buy |
| 2022-04-19 | 開始されました | Wedbush | Outperform |
すべてを表示
Vera Therapeutics Inc (VERA) 最新ニュース
Published on: 2025-07-30 16:01:27 - metal.it
Can Vera Therapeutics Inc. stock recover from recent declineWeekly Hot Picks With Buy Confidence Released - beatles.ru
What are the technical indicators suggesting about Vera Therapeutics Inc.Swing Trade Forecasts For Smart Trading - jammulinksnews.com
Why is Vera Therapeutics Inc. stock attracting strong analyst attentionSwing Trade Report To Watch Now - jammulinksnews.com
How volatile is Vera Therapeutics Inc. stock compared to the marketAchieve breakthrough gains with expert advice - jammulinksnews.com
What are Vera Therapeutics Inc. company’s key revenue driversInvest confidently with data-backed picks - jammulinksnews.com
What are analysts’ price targets for Vera Therapeutics Inc. in the next 12 monthsCapitalize on market trends before they peak - jammulinksnews.com
Is Vera Therapeutics Inc. a growth stock or a value stockGet professional advice for portfolio optimization - jammulinksnews.com
What catalysts could drive Vera Therapeutics Inc. stock higher in 2025Unlock daily market insights for better trades - jammulinksnews.com
Does Vera Therapeutics Inc. stock perform well during market downturnsAccess high-yield investment alerts now - jammulinksnews.com
Will Vera Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsFree Stock Investment Discussion Area - metal.it
Behind The Volatility Of Vera Therapeutics (NASDAQ:VERA) - Seeking Alpha
Vera Therapeutics Reports Positive Phase 3 ORIGIN Trial Results for Atacicept in IgA Nephropathy - MSN
Vera Therapeutics Inc. Stock Analysis and ForecastHigh-performance investment picks - PrintWeekIndia
Does Vera Therapeutics Inc. stock pay reliable dividendsRapid market gains - jammulinksnews.com
Why Vera Therapeutics Inc. stock is on top investor watchlistsRemarkable growth - jammulinksnews.com
What analysts say about Vera Therapeutics Inc. stockLightning-fast capital gains - Autocar Professional
What drives Vera Therapeutics Inc. stock priceFree Trading Strategy Suggestions - Autocar Professional
Is Vera Therapeutics Inc. a good long term investmentUnstoppable trading performance - jammulinksnews.com
Polycythemia Vera Pipeline 2025: Latest FDA Approvals, - openPR.com
Fund Remains in Vera Therapeutics Short-Swing Trading Lawsuit - Bloomberg Law News
Vera Therapeutics Inc (VERA) 財務データ
収益
当期純利益
現金流量
EPS
Vera Therapeutics Inc (VERA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
2.79%
2.01%
大文字化:
|
ボリューム (24 時間):